Evidence map›Paper›PMID 30885720›Full record

ArticleMethods (San Diego, Calif.)2019

MetaPheno: A critical evaluation of deep learning and machine learning in metagenome-based disease prediction.

Nathan LaPierre, Chelsea J-T Ju, Guangyu Zhou, Wei Wang

Abstract read
In one paragraph

Article in Methods (San Diego, Calif.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. A survey of k-mer methods and applications in bioinformatics.Computational and structural biotechnology journal · 2024
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Scientific novelty beyond the experiment.Microbial biotechnology · 2023
    Article
  18. Article
  19. POPDx: an automated framework for patient phenotyping across 392 246 individuals in the UK Biobank study.Journal of the American Medical Informatics Association : JAMIA · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nathan LaPierreDepartment of Computer Science, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Chelsea J-T JuDepartment of Computer Science, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Guangyu ZhouDepartment of Computer Science, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Wei WangDepartment of Computer Science, University of California at Los Angeles, Los Angeles, CA 90095, USA. Electronic address: weiwang@cs.ucla.edu.

Funding

Medical Imaging Informatics Training GrantT32EB016640 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALEX BUI, William Hsu · 2013 to 2026
$2.3M
Fast and Robust Methods for Large Scale Genotype Phenotype Association StudyR01GM115833 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WANG, WEI · 2015 to 2017
$933k
NIBIB NIH HHS T32 EB016640NIGMS NIH HHS R01 GM115833
6 · The paper itself

Abstract

The human microbiome plays a number of critical roles, impacting almost every aspect of human health and well-being. Conditions in the microbiome have been linked to a number of significant diseases. Additionally, revolutions in sequencing technology have led to a rapid increase in publicly-available sequencing data. Consequently, there have been growing efforts to predict disease status from metagenomic sequencing data, with a proliferation of new approaches in the last few years. Some of these efforts have explored utilizing a powerful form of machine learning called deep learning, which has been applied successfully in several biological domains. Here, we review some of these methods and the algorithms that they are based on, with a particular focus on deep learning methods. We also perform a deeper analysis of Type 2 Diabetes and obesity datasets that have eluded improved results, using a variety of machine learning and feature extraction methods. We conclude by offering perspectives on study design considerations that may impact results and future directions the field can take to improve results and offer more valuable conclusions. The scripts and extracted features for the analyses conducted in this paper are available via GitHub:https://github.com/nlapier2/metapheno.

Indexed as

Deep LearningAlgorithmsDiabetes Mellitus, Type 2HumansMachine LearningMetagenomeMetagenomicsMicrobiotaObesityDeep learningMachine learningMetagenomicsPhenotype prediction

Identifiers

PMID30885720
PMCPMC6708502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.